Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
09 February 1989Website:
http://www.bio-techne.comNext earnings report:
31 January 2025Last dividends:
08 November 2024Next dividends:
N/APrice
pre-market | 107 min agoAnalysts recommendations
Institutional Ownership
Included in screeners
TECH Latest News
TECH is experiencing ongoing growth in its Diagnostics and Spatial Biology division.
On Wednesday, Bio-Techne exceeded profit expectations for the first quarter, thanks to growth in its diagnostics and spatial biology areas. This news caused the biotech company's shares to rise by 4.59% in premarket trading.
On October 29, 2024, in St. Paul, Minnesota, ScaleReady, together with Wilson Wolf Manufacturing and Bio-Techne Corporation, announced that Luminary Therapeutics has received a G-Rex® Grant worth $300,000.
A new training program is being introduced to address the increasing need for Hyundai and Genesis automotive technicians across the country. This initiative aims to prepare more skilled workers for these roles. It responds to the rising demand in the automotive industry.
SCOTTSDALE, Ariz., Oct. 10, 2024 /PRNewswire/ -- Cyber Enviro-Tech Inc. (CETI) (OTCQB: CETI) is excited to share that it has formed a partnership with its subsidiary, CETI Axenic (CAX), which is owned by its shareholders, to explore possibilities in the commercial laundry sector.
The award will help with the clinical production of the Company's promising Neutrophil-only Leukocyte Infusion Therapy (N-LIfT) platform in St. Paul, Minnesota.
On October 8, 2024, in St. Paul, Minnesota, ScaleReady™ announced a partnership with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady™. They revealed that Eric Tran, Ph.D., is now an Associate Member of the Earle A.
On October 7, 2024, in St. Paul, Minnesota, ScaleReady™ announced a partnership with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady™. Christopher A. was mentioned in their announcement.
On September 18, 2024, in St. Paul, Minnesota, ScaleReady™ announced a partnership with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady™ to work with ImmunoScape Pte.
NEW ORLEANS, LA / ACCESSWIRE / September 12, 2024 / Kahn Swick & Foti, LLC ("KSF") and their partner, former Louisiana Attorney General Charles C. Foti, Jr., want to remind investors that the deadline to submit lead plaintiff applications in a securities class action lawsuit against ODDITY Tech Ltd. is September 17, 2024.
What type of business is Bio-Techne?
Bio-Techne Corporation and its subsidiaries develop, manufacture, and sell biological reagents, tools, and services for research, diagnostic, and bioprocessing markets worldwide. The company was founded in 1976. The headquarters is located in Minneapolis, Minnesota. The corporation has a deep product portfolio and expertise in applications, selling essential components for scientific research of biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology, and progression of specific diseases. Bio-Techne products help create drugs and provide tools for precise clinical tests and diagnoses.
What sector is Bio-Techne in?
Bio-Techne is in the Healthcare sector
What industry is Bio-Techne in?
Bio-Techne is in the Biotechnology industry
What country is Bio-Techne from?
Bio-Techne is headquartered in United States
When did Bio-Techne go public?
Bio-Techne initial public offering (IPO) was on 09 February 1989
What is Bio-Techne website?
https://www.bio-techne.com
Is Bio-Techne in the S&P 500?
Yes, Bio-Techne is included in the S&P 500 index
Is Bio-Techne in the NASDAQ 100?
No, Bio-Techne is not included in the NASDAQ 100 index
Is Bio-Techne in the Dow Jones?
No, Bio-Techne is not included in the Dow Jones index
When was Bio-Techne the previous earnings report?
No data
When does Bio-Techne earnings report?
The next expected earnings date for Bio-Techne is 31 January 2025